Spire Healthcare Group (LON:SPI) was upgraded by equities research analysts at Berenberg Bank to a “buy” rating in a note issued to investors on Wednesday, November 29th, MarketBeat.com reports. The brokerage currently has a GBX 310 ($4.14) target price on the stock, up from their prior target price of GBX 270 ($3.61). Berenberg Bank’s target price would suggest a potential upside of 22.24% from the stock’s current price.

Other research analysts have also issued reports about the company. Numis Securities reiterated an “add” rating and issued a GBX 341 ($4.56) target price on shares of Spire Healthcare Group in a report on Monday, October 23rd. Liberum Capital reiterated a “hold” rating and issued a GBX 270 ($3.61) target price on shares of Spire Healthcare Group in a report on Thursday, November 16th. Jefferies Group decreased their target price on Spire Healthcare Group from GBX 350 ($4.68) to GBX 259 ($3.46) and set a “hold” rating for the company in a report on Monday, September 25th. Finally, JPMorgan Chase & Co. decreased their target price on Spire Healthcare Group from GBX 376 ($5.03) to GBX 339 ($4.53) and set a “neutral” rating for the company in a report on Friday, September 15th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and one has assigned a buy rating to the stock. Spire Healthcare Group presently has an average rating of “Hold” and a consensus target price of GBX 309.86 ($4.14).

Spire Healthcare Group (LON:SPI) traded up GBX 3.40 ($0.05) during trading hours on Wednesday, reaching GBX 253.60 ($3.39). The company had a trading volume of 413,419 shares, compared to its average volume of 2,210,000. The stock has a market capitalization of $1,020.00 and a price-to-earnings ratio of 3,622.86. Spire Healthcare Group has a 52-week low of GBX 218.20 ($2.92) and a 52-week high of GBX 362.10 ($4.84).

In other news, insider Peter R. Bamford bought 5,000 shares of the business’s stock in a transaction dated Monday, November 27th. The shares were acquired at an average price of GBX 240 ($3.21) per share, for a total transaction of £12,000 ($16,044.93). Also, insider Justin Ash bought 84,500 shares of the business’s stock in a transaction dated Thursday, November 23rd. The shares were purchased at an average price of GBX 237 ($3.17) per share, for a total transaction of £200,265 ($267,769.76).

COPYRIGHT VIOLATION WARNING: “Spire Healthcare Group (SPI) Raised to “Buy” at Berenberg Bank” was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this news story on another website, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The legal version of this news story can be viewed at https://www.americanbankingnews.com/2017/12/31/spire-healthcare-group-spi-raised-to-buy-at-berenberg-bank.html.

Spire Healthcare Group Company Profile

Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.

Analyst Recommendations for Spire Healthcare Group (LON:SPI)

Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.